Geoffrey S Ginsburg. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AnimalsApolipoprotein B-100/immunologyAtherosclerosis/drug therapyAtherosclerosis/immunologyAtherosclerosis/pathologyHumansImmunoglobulin G/administration & dosageImmunoglobulin G/therapeutic useImmunologic Factors/administration & dosageImmunologic Factors/therapeutic useMicePeptide Fragments/immunologyReceptors, Oxidized LDL/physiologyRecombinant Proteins/administration & dosageRecombinant Proteins/therapeutic use
Substances： See more » Apolipoprotein B-100Immunoglobulin GImmunologic FactorsPeptide FragmentsReceptors, Oxidized LDLRecombinant Proteinsapolipoprotein B-100 (661-680), human
Year: 2007 PMID： 18068041 DOI： 10.1016/j.jacc.2007.08.039
Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094